Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to $52.0 million.

  • Corcept Therapeutics' Change in Acquisitions & Divestments fell 7122.83% to $52.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $337.9 million, marking a year-over-year decrease of 1098.05%. This contributed to the annual value of $412.9 million for FY2024, which is 164.72% down from last year.
  • As of Q3 2025, Corcept Therapeutics' Change in Acquisitions & Divestments stood at $52.0 million, which was down 7122.83% from $93.5 million recorded in Q2 2025.
  • Corcept Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $207.5 million for Q1 2023, and its period low was $42.1 million during Q1 2022.
  • Over the past 5 years, Corcept Therapeutics' median Change in Acquisitions & Divestments value was $80.3 million (recorded in 2024), while the average stood at $91.1 million.
  • In the last 5 years, Corcept Therapeutics' Change in Acquisitions & Divestments skyrocketed by 39249.89% in 2023 and then tumbled by 7122.83% in 2025.
  • Over the past 5 years, Corcept Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $90.1 million in 2021, then fell by 11.81% to $79.4 million in 2022, then crashed by 40.83% to $47.0 million in 2023, then skyrocketed by 70.92% to $80.3 million in 2024, then crashed by 35.27% to $52.0 million in 2025.
  • Its last three reported values are $52.0 million in Q3 2025, $93.5 million for Q2 2025, and $112.1 million during Q1 2025.